Document QXVdan35w4R3kKRbdV3K1301k

March 1, 2024 ELECTRONIC MAIL CONFIRMATION OF RECEIPT EMAIL REQUESTED Clement Aikens Sr. Manager DEA & EHS Compliance Noven Pharmaceuticals, Inc. 11960 SW 144Th St Miami, FL 33186 caikens@noven.com SUBJ: Resource Conservation and Recovery Act (RCRA) Compliance Evaluation Inspection (CEI) Noven Pharmaceuticals, Inc. EPA ID No.: FL0000545921 Dear Clement Aikens: On January 25, 2024, the U.S. Environmental Protection Agency, along with the Florida Department of Environmental Protection (FDEP) conducted a CEI at Noven Pharmaceuticals, Inc. located in Miami, Florida, to determine the facility's compliance status with RCRA and applicable regulations. Enclosed is the EPA RCRA Inspection Report which indicates that deficiencies of RCRA were discovered during the inspection. A copy of this report has been forwarded to the FDEP for follow up and further review. If you have any questions regarding this matter, please contact Nereida Hernandez Morales, of my staff, by phone at (404) 562-8289 or by email at HernandezMorales.Nereida@epa.gov. Sincerely, Digitally signed ARACELI by ARACELI CHAVEZ CHAVEZ Date: 2024.03.01 09:14:18 -05'00' Araceli B. Chavez Chief RCRA Enforcement Section ENCLOSURE 1. RCRA Inspection Report cc: Johanna Polycart, FDEP, Johanna.Polycart@FloridaDEP.gov Jeff Gregg, FDEP, Jeff.Gregg@FloridaDEP.gov Kaitlyn Taylor, FDEP. Kaitlyn.A.Taylor@FloridaDEP.gov Nereida Hernandez Morales, EPA, hernandezmorales.nereida@epa.gov 2